HappeningToo topic
Eculizumab reports
Browse community reports connected to Eculizumab. These reports can show that other people are describing similar experiences, but they do not prove that Eculizumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
33 problems
Abdominal Pain Upper while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and abdominal pain upper appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and abdominal pain appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and alopecia appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and anxiety appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and back pain appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and chills appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and cough appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and decreased appetite appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and dehydration appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and diarrhea appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and dizziness appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and fatigue appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and feeling abnormal appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and headache appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and hypotension appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and insomnia appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and itching appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and malaise appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and migraine appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and muscle spasms appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and muscular weakness appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and myalgia appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and nausea appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and oropharyngeal pain appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and pain appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and peripheral swelling appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and rash appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and shortness of breath appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and sleepiness appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and vomiting appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and weakness appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and weight decreased appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Eculizumab
FDA FAERS contains adverse-event reports in which Eculizumab and weight increased appear together. This does not establish that Eculizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →